Literature DB >> 12105165

Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection.

Parvaneh Rafiee1, Yang Shi, Xiangrong Kong, Kirkwood A Pritchard, James S Tweddell, S Bert Litwin, Kathleen Mussatto, Robert D Jaquiss, Jidong Su, John E Baker.   

Abstract

BACKGROUND: Many infants who undergo heart surgery have a congenital cyanotic defect in which the heart is chronically perfused with hypoxic blood. However, the signaling pathways by which infant hearts adapt to chronic hypoxia and resist subsequent surgical ischemia is unknown. METHODS AND
RESULTS: We determined the activation and translocation of protein kinase C (PKC) isoforms and mitogen activated protein kinases (MAP kinases) in 15 infants with cyanotic (SaO2<85%) or acyanotic (SaO2>95%) heart defects undergoing surgical repair and in 80 rabbits raised from birth in a hypoxic (SaO2<85%) or normoxic (SaO2>95%) environment. Tissues from infant human and rabbit hearts were processed for Western and in vitro kinase analysis. In human infants with cyanotic heart defects, PKCepsilon, p38 MAP kinase, and JUN kinase but not p42/44 MAP kinase were activated and translocated from the cytosolic to the particulate fraction compared with acyanotic heart defects. In rabbit infants there was a parallel response for PKCepsilon, p38 MAP kinase, and JUN kinase similar to humans. In infant rabbit hearts inhibition of PKCepsilon with chelerythrine, p38 MAP kinase, with SB203580 and JUN kinase with curcumin abolished the cardioprotective effects of chronic hypoxia but had no effects on normoxic hearts.
CONCLUSIONS: Infant human and rabbit hearts adapt to chronic hypoxia through activation of PKCepsilon, p38 MAP kinase, and JUN kinase signal transduction pathways. These pathways may be responsible for cardioprotection in the chronically hypoxic infant rabbit heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105165     DOI: 10.1161/01.cir.0000022018.68965.6d

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  New insight into the signalling pathways of heat stress-induced myocardial preconditioning: protein kinase Cepsilon translocation and heat shock protein 27 phosphorylation.

Authors:  Claire Arnaud; Marie Joyeux-Faure; Serge Bottari; Diane Godin-Ribuot; Christophe Ribuot
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-03       Impact factor: 2.557

2.  Role of FAT/CD36 in novel PKC isoform activation in heart of spontaneously hypertensive rats.

Authors:  Martina J Klevstig; Irena Markova; Jana Burianova; Ludmila Kazdova; Michal Pravenec; Olga Novakova; Frantisek Novak
Journal:  Mol Cell Biochem       Date:  2011-05-31       Impact factor: 3.396

3.  Activation of protein kinase C ε enhanced movement ability and paracrine function of rat bone marrow mesenchymal stem cells partly at least independent of SDF-1/CXCR4 axis and PI3K/AKT pathway.

Authors:  Hua He; Zhi-Hong Zhao; Fu-Sheng Han; Xi-Fu Wang; Yu-Jie Zeng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.

Authors:  Tána Ravingerová; Jana Matejíková; Jan Neckár; Eva Andelová; Frantisek Kolár
Journal:  Mol Cell Biochem       Date:  2006-10-03       Impact factor: 3.396

5.  PKCε promotes cardiac mitochondrial and metabolic adaptation to chronic hypobaric hypoxia by GSK3β inhibition.

Authors:  Joy McCarthy; Amanda Lochner; Lionel H Opie; Michael N Sack; M Faadiel Essop
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

6.  Up-regulation and redistribution of protein kinase C-δ in chronically hypoxic heart.

Authors:  Markéta Hlaváčková; Kristýna Kožichová; Jan Neckář; František Kolář; René J P Musters; František Novák; Olga Nováková
Journal:  Mol Cell Biochem       Date:  2010-09-19       Impact factor: 3.396

7.  Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats.

Authors:  John E Baker; Jidong Su; Anna Hsu; Yang Shi; Ming Zhao; Jennifer L Strande; Xiangping Fu; Hao Xu; Annie Eis; Richard Komorowski; Eric S Jensen; James S Tweddell; Parvaneh Rafiee; Garrett J Gross
Journal:  Cardiovasc Res       Date:  2007-09-22       Impact factor: 10.787

8.  Chronic intermittent hypoxia affects the cytosolic phospholipase A2α/cyclooxygenase 2 pathway via β2-adrenoceptor-mediated ERK/p38 stimulation.

Authors:  Petra Micova; Klara Hahnova; Marketa Hlavackova; Barbara Elsnicova; Anna Chytilova; Kristyna Holzerova; Jitka Zurmanova; Jan Neckar; Frantisek Kolar; Olga Novakova; Jiri Novotny
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

Review 9.  The involvement of protein kinases in the cardioprotective effect of chronic hypoxia.

Authors:  N V Naryzhnaya; H-J Ma; L N Maslov
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

Review 10.  Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials.

Authors:  Seung-Kwon Myung; Woong Ju; Belong Cho; Seung-Won Oh; Sang Min Park; Bon-Kwon Koo; Byung-Joo Park
Journal:  BMJ       Date:  2013-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.